Registration for a live webinar on 'Precision medicine treatment for anticancer drug resistance' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
- Structure of the blood-brain barrier
-
1. The blood-brain barrier in Alzheimer’s disease
- Dr. Anika Hartz
-
2. Tanycytes allow a tight BBB in the median eminence
- Prof. Esteban Rodriguez
- Dr. Juan Luis Blazquez
- Dr. Montserrat Guerra
- Nutrient transport
-
3. Blood-brain barrier ion transport
- Prof. Martha O'Donnell
- Peptides and proteins
-
4. Ingestive peptides
- Prof. William Banks
-
5. Blood-brain barrier in health and disease
- Prof. Thomas Davis
- Overcoming the blood-brain barrier obstacle
-
6. Expression vs. function of ABC transporters at the blood-brain barrier
- Prof. Jean-Michel Scherrmann
-
7. The blood-brain barrier and CNS drug development
- Dr. Danica Stanimirovic
- Diseases involving the blood-brain barrier
-
9. Inflammation and immune cell entry to the central nervous system
- Prof. Serge Rivest
-
11. Ischemic blood-brain barrier and Alzheimer's amyloid plaques development
- Prof. Ryszard Pluta
- Latest Developments in the Field
-
12. MRI approaches for neurovascular imaging
- Dr. Rick Dijkhuizen
-
13. Brain-gut interactions in obesity 1
- Prof. Weihong Pan
-
14. Brain-gut interactions in obesity 2
- Prof. Weihong Pan
- Archived Lectures *These may not cover the latest advances in the field
-
15. Neurotrophins and the BBB
- Prof. Weihong Pan
-
16. Vasoactive peptides and the blood-brain barrier
- Prof. Maria Deli
- Prof. Bela Kis
-
17. In vivo systems
- Prof. Quentin Smith
-
18. CNS-drug design
- Prof. Quentin Smith
-
20. Stroke and the BBB
- Prof. Marilyn Cipolla
-
21. Barrier mechanisms in the developing brain: mechanisms and misunderstandings
- Prof. Norman Saunders
-
22. Barrier mechanisms in the developing brain: protection or vulnerability?
- Prof. Norman Saunders
-
23. In vitro models of the blood-brain barrier
- Prof. Pierre-Olivier Couraud
-
24. Glucose transport across the blood-brain barrier
- Prof. Luc Leybaert
-
25. The blood-brain barrier and brain tumors
- Dr. Olaf van Tellingen
-
26. Cellular composition of the blood-brain barrier
- Prof. N. Joan Abbott
-
27. Features of mammalian CNS barrier systems
- Prof. Conrad Johanson
Printable Handouts
Navigable Slide Index
- Introduction
- Lecture outline
- The blood-brain-barrier
- Cellular architecture of the BBB
- Pericytes
- Molecular characteristics of the BBB
- Reference in vitro models of the BBB
- Cultured brain microvascular endothelial cells
- Phenotypic markers of brain endothelial cell
- BBB in vitro models
- Example of a co-culture system
- In vitro permeability assay
- Trans-endothelial electrical resistance (TEER)
- In vitro and in vivo drug permeability
- Drug permeability of various in vitro models
- Immortalization of rat brain endothelial cells
- Primary BMECs vs. immortalized cell lines
- A new model of human BBB
- Immortalization of human brain endothelial cells
- hCMEC/D3: a non-transformed phenotype (1)
- hCMEC/D3: a non-transformed phenotype (2)
- hCMEC/D3: expression of junction proteins (1)
- hCMEC/D3: expression of junction proteins (2)
- Permeability characteristics of hCMEC/D3 cells
- Efflux pupms: ABC transporters
- hCMEC/D3: functionality of ABC transporters
- The hCMEC/D3 cell line
- The hCMEC/D3 model under flow
- hCMEC/D3 in a DIV-BBB device
- Hyperosmolar opening of BBB in DIV models
- Radioactive sucrose permeability in DIV models
- hCMEC/D3 in a DIV-BBB device: conclusions
- Applications of in vitro models of the BBB
- BBB: physiological and pathophysiological roles
- In vitro BBB models and research axes
- Leukocyte infiltration across the BBB
- Response to cell adhesion and transmigration
- ICAM-1and PECAM-1 signaling
- Tight junctions, receptors and transporters
- Analysis of TJ proteomes in hCMEC/D3 cells
- Multiple reaction monitoring (MRM)
- Analysis by quantitative mass spectrometry
- Optimizing drug delivery to the brain
- BBB in vitro models: conclusions, perspectives
- Acknowledgments
Topics Covered
- Blood-brain barrier
- In vitro models of blood-brain barrier
- Blood-brain barrier permeability
- Brain endothelium and tight junctions
- Transporters at the blood-brain barrier
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Couraud, P. (2008, March 1). In vitro models of the blood-brain barrier [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved December 21, 2024, from https://doi.org/10.69645/HWFO8391.Export Citation (RIS)
Publication History
Financial Disclosures
- Prof. Pierre-Olivier Couraud has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.